Status:
RECRUITING
TROPOnin FRAGMentation in Myocardial Injury Study
Lead Sponsor:
University of Turku
Conditions:
Acute Myocardial Infarction Type 1
Myocardial Injury
Eligibility:
All Genders
18+ years
Brief Summary
Troponin T (TnT) is a part of the troponin protein complex that principally exists in cardiac and skeletal muscle cells and is widely used as diagnostic biomarker for myocardial injury and, thus, myoc...
Detailed Description
Modern cardiac troponin T (cTnT) tests are highly sensitive in diagnosing AMI and myocardial damage. Atrial fibrillation and many non-cardiac conditions and even strenuous exercise are associated with...
Eligibility Criteria
Inclusion
- Troponin T fragmentation sample collected from a recruited patient.
Exclusion
- Age \<18
Key Trial Info
Start Date :
April 2 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT04465591
Start Date
April 2 2020
End Date
December 31 2026
Last Update
August 14 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Turku University Hospital, Heart Center
Turku, Southwest Finland, Finland, 20521
2
University Hospital Zurich
Zurich, Switzerland, 8091 Zurich